Pretargeted radioimmunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pretargeted radioimmunotherapy, covering 2017-08-30 to 2017-08-30. Get the full timeline:
Most recent: Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]